Search

everythinglearnresearchcommunity

for

Search:↓

The document suggests that clinical trials for PCOS should focus on meaningful primary outcomes like live birth rates, rather than less reliable surrogate markers.

Teens with PCOS and a mom with PCOS have higher insulin resistance and lower adiponectin levels, which could signal early metabolic problems.

Common Black hair care products may affect hormone levels and potentially impact health, especially in reproductive and metabolic areas.

Scalp cooling to prevent hair loss from chemotherapy works for some but not all, and studying hair damage markers could improve prevention and treatment.

The document concludes that managing PCOS involves treating symptoms, regulating periods, and reducing health risks, with specific medications for fertility and metabolic issues.

Ayurvedic Panchakarma therapy, Virechan, can effectively manage PCOS symptoms and improve health markers.

FPHL causes hair loss in women due to genetics and hormones; minoxidil and anti-androgens are treatments, and early intervention is advised.

Women with PCOS are at higher risk for gum disease, and managing shared risk factors can help both conditions.

Alopecia patients have higher heart disease risk; statins and finasteride may help.

Researchers found a new gene area linked to male-pattern baldness, which, along with another gene, significantly increases the risk of hair loss in men.

The guide explains how to study human and mouse sebaceous glands using various staining and imaging techniques, and emphasizes the need for standardized assessment methods.

Non-immune factors play a significant role in alopecia areata.

Rosuvastatin improves lipid levels, reduces inflammation, but worsens insulin sensitivity in men with early-onset hair loss.

Recombinant human growth hormone helps burn wounds heal faster by increasing blood vessel growth.

Blue light helps hair growth by affecting specific proteins in hair follicle cells.

No link between hair loss and blood groups or Rhesus factor.

The 2003 consensus updated PCOS diagnosis criteria and highlighted increased risks of diabetes and heart disease for those affected.

The 2003 consensus updated PCOS diagnosis criteria and linked PCOS to higher risks of diabetes and heart problems, recommending lifestyle changes to lower these risks.

PCOS is a complex condition with major health impacts, needing more research for better diagnosis and treatment.

Photobiomodulation therapy using red and near-infrared light can reduce inflammation and aid in healing various conditions.

While PCOS might increase the risk of heart disease, there's not strong evidence to prove it causes earlier heart problems.

Dehydroepiandrosterone (DHEA) is a prohormone important for producing sex steroids and has potential health benefits.

Cushing's syndrome can cause serious health problems, and early treatment is crucial, but some issues may remain after treatment.

The Endocrine Society advised against routine testosterone therapy for women, citing a need for more research on long-term safety and a clear definition of androgen deficiency.

The document provides a method to classify human hair growth stages using a model with human scalp on mice, aiming to standardize hair research.

Diagnosing PCOS in teenagers is challenging and should use strict criteria to avoid misdiagnosis and unnecessary worry.

Metformin helps manage polycystic ovary syndrome by improving insulin resistance and ovulation, but more research is needed on its full effects.

Early diagnosis and individualized treatment improve outcomes for Congenital Adrenal Hyperplasia.

The update highlights that non-classic congenital adrenal hyperplasia is common in women with excess male hormones, requires specific hormone tests for diagnosis, and has various treatment options depending on age and symptoms.

Combining liraglutide and metformin helps obese women with PCOS who didn't lose weight on metformin alone to lose more weight.